Kathmere Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $896K | Sell |
2,302
-375
| -14% | -$146K | 0.07% | 180 |
|
|
2025
Q1 | $1.16M | Buy |
2,677
+1,592
| +147% | +$692K | 0.1% | 129 |
|
|
2024
Q4 | $400K | Buy |
+1,085
| New | +$400K | 0.04% | 269 |
|
|
2024
Q3 | – | Sell |
-388
| Closed | -$210K | – | 384 |
|
|
2024
Q2 | $210K | Buy |
+388
| New | +$210K | 0.02% | 313 |
|
|
2022
Q3 | – | Sell |
-626
| Closed | -$302K | – | 174 |
|
|
2022
Q2 | $302K | Buy |
626
+26
| +4% | +$12.5K | 0.06% | 121 |
|
|
2022
Q1 | $295K | Buy |
600
+136
| +29% | +$66.9K | 0.05% | 129 |
|
|
2021
Q4 | $215K | Buy |
+464
| New | +$215K | 0.04% | 130 |
|
|
2021
Q1 | – | Sell |
-462
| Closed | -$148K | – | 221 |
|
|
2020
Q4 | $148K | Buy |
462
+14
| +3% | +$4.49K | 0.03% | 155 |
|
|
2020
Q3 | $120K | Sell |
448
-313
| -41% | -$83.8K | 0.03% | 152 |
|
|
2020
Q2 | $200K | Buy |
+761
| New | +$200K | 0.06% | 111 |
|